Interdisciplinary coordination between nephrologists, primary care providers, pharmacists, dieticians, and everyone who interacts with patients is essential to ensure patient education, improve adherence, and reduce medication errors. The post More Medications, Less Clarity: Strengthening Polypharmacy Support for CKD Patients appeared first on MedCity News.

The between a code that satisfies a payer and the information a physician needs to treat a person, is what nearly every healthcare AI tool is racing past. As we push these systems toward precision medicine and genomics, that gap stops being an annoyance and becomes a patient safety issue. The post The Code Gets You Paid — The Variant Gets You Treated appeared first on MedCity News.

[Sponsored] A new whitepaper by League highlights examples from collaborations with Baptist Health. The post Moving Beyond Reactive Healthcare: 5 Traits of Successful Healthcare Organizations appeared first on MedCity News.

Doctronic acquired Summer Health to expand into pediatric care and strengthen its AI-powered primary care platform. The post Doctronic Acquires Summer Health to Expand into Pediatric Primary Care appeared first on MedCity News.

With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that offers pipeline-in-a-product potential addressing a target that has clinical and regulatory validation from a recently approved Novartis drug. Vidya’s molecule is a next-generation drug that could have advantages over Novartis’s pill. The post Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis Product appeared first on MedCity News.

A survey of 112 health system executives finds that Epic’s hold on hospital IT keeps getting stronger — but startups still have a shot, provided they solve a specific problem, prove strong ROI or offer a product that Epic is lagging behind on. The post Epic-First Doesn’t Mean Epic-Only: Where Hospitals Are Still Buying from Startups appeared first on MedCity News.

CMS’s new framework sounds like a gentle opt-in. There’s no requirement to meet every standard on day one, just a commitment to work toward doing the right thing. That sounds great. But to actually participate in the network, you have to meet a baseline level of interoperability. The post A New Era of Interoperability, But Who Gets Left Behind? appeared first on MedCity News.

The most common and most expensive misunderstanding in healthcare cloud strategy is treating the cloud as a destination you either reach or you do not, when it is really a progression through five distinct stages, each one unlocking capabilities the stage before it could not support. The post The Healthcare Cloud Maturity Model: The Five Stages Most Health Systems Skip appeared first on MedCity News.

Throne Science — a startup selling an AI-powered toilet camera that tracks gut health, hydration and urinary function — closed a $10 million Series A funding round. CEO Scott Hickle said the goal is to become a “smoke detector for colorectal cancer,” filling a monitoring gap he noted the wearables industry has largely ignored. The post Smart Toilet Sensor Startup Is Flush with $10M Funding appeared first on MedCity News.

Included Health announced plans to acquire Firefly Health to accelerate its alternative health plan strategy for employers. The post Included Health to Acquire Firefly Health to Expand Alternative Health Plan Offering for Employers appeared first on MedCity News.

Altimmune’s pemvidutide achieved a statistically significant reduction in heavy drinking days compared to a placebo in a Phase 2 trial. This peptide drug, which is designed to activate the GLP-1 and glucagon receptors, is also on track to begin a pivotal test in the fatty liver disease MASH. The post Altimmune’s GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder Trial appeared first on MedCity News.

Done well, NICU UM is so much more than an approval process. It is a clinical credibility engine that — when integrated with Case Management (CM) — drives every NICU admission toward the most appropriate, impactful care. The post Why Specialized UM Delivers on Every NICU Outcome appeared first on MedCity News.

A few minutes of interaction with a digital tablet and speaking can reveal patterns that once required advanced imaging, years of observation, or were just completely undetectable.  The post Spotting Alzheimer’s Years Earlier Through AI and Clinically Meaningful Insights appeared first on MedCity News.

Lakshmi Halasyamani, chief clinical officer at Endeavor Health, thinks value-based care isn’t really about payment models. To her, this work centers on understanding patients’ clinical, social and financial circumstances well enough to make care plans that actually work for their lives. The post Why Endeavor Health Refuses to Silo Its Value-Based Care Strategy appeared first on MedCity News.

Argenx’s first acquisition is the buyout of Forte Biosciences, a company with a lead drug that has early clinical validation in celiac disease and vitiligo. Argenx executives say this antibody complements its blockbuster product Vyvgart, offering a different mechanism of action but similar pipeline-in-a-product potential. The post Argenx’s $2B Forte Bio Acquisition Brings Autoimmune Playbook to Prevalent Disorders appeared first on MedCity News.